Could your research be a startup? Coffee Exchange with Manuel Kaulich
Manuel Kaulich is a professor at Goethe University Frankfurt and co-founder of Vivlion, a university spin-off that turned a CRISPR method from his lab into CRISPR screening libraries and today partners with biotech companies. Over coffee, he'll share what he learned the hard way and what he would do differently today.
On the table
Do I have to leave academia to start a company?
Who owns my research, and how do I get it out of the university?
When is a method a business, and when is it just a good paper?
Who should join
Researchers thinking about spinning out and early-stage founders. No idea or business plan needed.
The format is informal: short input, lots of room for your questions, good conversations over coffee.
Seats are limited, so save your spot now.
A Futury x PROXIDRUGS event.